Natural history of adult T-cell leukemia/lymphoma and approaches to therapy (Q34450097)

2 August 2017

1 reference

title

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy (English)

1 reference

adult T-cell leukemia/lymphoma

2 August 2017

1 reference

1 reference

Masao Matsuoka

2

0 references

author name string

Graham P Taylor

series ordinal

1

1 reference

PubMed ID

16155611

2 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

2 August 2017

1 reference

2 August 2017

24

1 reference

2 August 2017

6047-6057

1 reference

2 August 2017

39

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208979

2 August 2017

0 references

cites work

Long-term serological outcome of infants who received frozen-thawed milk from human T-lymphotropic virus type-I positive mothers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Anti-tumor mechanisms of valproate: a novel role for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Adult T-cell leukemia: future prophylaxis and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

A Retrospective Study on Transmission of Adult T Cell Leukemia Virus by Blood Transfusion: Seroconversion in Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Human T-cell lymphotropic-I-associated leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

The current status of therapy for adult T-cell leukaemia-lymphoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia–lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

T-cell control by human T-cell leukemia/lymphoma virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Hypercalcemia and osteoclast proliferation in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

The role of CD95 in the regulation of peripheral T-cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Human T-cell leukemia virus type I at age 25: a progress report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappa B ligand on adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Phase II study of cladribine (2-chlorodeoxyadenosine) in relapsed or refractory adult T-cell leukemia-lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Adult T-cell leukemia-lymphoma successfully treated with 2-chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Transcription start regions in the human genome are favored targets for MLV integration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Identification of aberrantly methylated genes in association with adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208979

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208979

1 reference

PubMed ID

16155611

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

16155611